期刊文献+

炎症性肠病患者血清IL-23、IL-17、IL-25含量及临床意义 被引量:9

原文传递
导出
摘要 目的探讨IL-23、IL-17及IL-25在炎症性肠炎(IBD)患者中的表达及意义。方法采用酶联免疫吸附法检测24例溃疡性结肠炎(UC组)、24例克罗恩病(CD组)患者及20例健康人(对照组)血清IL-23、IL-17及IL-25含量,比较三者在三组中的表达,分析三者与UC和CD疾病严重程度的相关性及三者之间的关系。结果 UC组和CD组中血清IL-23、IL-17表达均显著高于对照组,且与病情严重程度呈正相关(P<0.01);UC组和CD组中血清IL-25表达均显著低于对照组,且与病情严重程度呈负相关(P<0.01);IL-23与IL-17呈正相关,IL-23与IL-25呈负相关(P<0.05)。结论 IL-23、IL-17在IBD患者外周血中高表达,IL-23能促进IL-17分泌,扩大炎性反应;IL-25在IBD患者外周血中低表达,IL-25表达与IL-23呈负相关。IBD的发病机制与IL-23、IL-17表达调高及IL-25的表达调低密切相关。
作者 陈建华
出处 《中华临床医师杂志(电子版)》 2012年第3期133-134,共2页 Chinese Journal of Clinicians(Electronic Edition)
  • 相关文献

参考文献10

  • 1Sarra M,Pallone F,Macdonald TT. IL-23/IL-17 axis in IBD[J].In-flamm Bowel Dis,2010.1808-1813.
  • 2杨璇,马俊芬,刘占举.白细胞介素-23对炎症性肠病患者外周血自然杀伤细胞的免疫调节作用[J].中华消化杂志,2009,29(10):649-652. 被引量:3
  • 3Liu Z,Yadav PK,Xu X. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity[J].Journal of Leukocyte Biology,2011.597-606.
  • 4Bamias G,Cominelli F. Immunopathogenesis of inflarmnatory bowel disease:current concepts[J].Curt Opin Gestroenterol,2007.365-369.
  • 5Ahem PP,Izcue A,Maloy KJ. The interleukin-23 axis in intestinal inflammation[J].Immunological Reviews,2008.147-159.
  • 6Stritesky GL,Yeh N,Kaplan MH. IL-23 promotes maintenance but not commitment to the Thl7 lineage[J].Journal of Immunology,2008.5948-5955.
  • 7Fort MM,Cheung J,Yen D. IL-25 induces IL-4,IL-5,and IL-13 and Th2-associated pathologies in vivo[J].Immunity,2001.985-995.
  • 8Kleinschek MA,Owyang AM,Joyce-Shaikh B. IL-25 regulates Thl7 function in autoimmune inflammation[J].Journal of Experimental Medicine,2007.161-170.
  • 9苏婧玲,刘占举.白细胞介素-25在炎症性肠病患者中的表达及临床意义[J].中华消化杂志,2010,30(12):872-876. 被引量:8
  • 10Caruso R,Sana M,Stolfi C. Interleukin-25 inhibits interleukin-12 production and Thl cell-driven inflammation in the gut[J].Gastroenterology,2009.2270-2279.

二级参考文献15

  • 1刘占举,郭惠学,胡军,李富广,杜英.IL-12对炎症性肠病患者外周血和肠黏膜固有层淋巴细胞激活和炎症介质分泌的影响[J].郑州大学学报(医学版),2006,41(5):818-820. 被引量:12
  • 2段秀梅,谭岩,方艳秋,杨广民,王晓祺,刘晓琳,刘力华,许淑芬.羧基荧光素琥珀酰亚胺酯标记肿瘤细胞及其在细胞毒检测中的价值[J].中华检验医学杂志,2006,29(10):935-938. 被引量:2
  • 3许建中,张晓强,刘占举.白细胞介素-23在类风湿关节炎滑膜中的表达及意义[J].中华风湿病学杂志,2007,11(2):96-98. 被引量:13
  • 4Liu Z,Yang L,Cui Y,et al.I1-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.Inflamm Bowel Dis,2009,15:1133-1144.
  • 5Oppmann B,Lesley R,Blom B,et al.Novel p19 protein engages IL-12p40 to form a cytokine,IL-23.with biological activities similar as well as distinct from IL-12.Immunity.2000,13:715-725.
  • 6Langrish CL,Chen Y,Blumenschein WM,et al.IL-23 drives a pathogenic T cell population that induces autoimmune inflammation.J Exp Med,2005,201:233-240.
  • 7Yen D,Cheung J,Scheerens H,et al.IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6.J Clin Invest,2006,116:1310-1316.
  • 8Ahern PP.Izcue A,Maloy KJ,et al.The interleukin-23 axis in intestinal inflammation.Immunol Rev,2008,226:147-159.
  • 9Liu Z,Jiu J,Liu S,et al.Blockage of tumor necrosis factor prevents intestinal mucosal inflammation through downregulation of interleukin-23 secretion.J Autoimmun,2007,29:187-194.
  • 10Cederbrant K,Marcusson-Stahl M.Condevaux F,et al.NK-cell activity in immunotoxicity drug evaluation.Toxicology,2003,185:241-250.

共引文献8

同被引文献110

引证文献9

二级引证文献168

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部